Gold R - Search Results

1

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, O'Neill GN; BG-12 Phase IIb Study Investigators. Kappos L, et al. Among authors: gold r. Lancet. 2008 Oct 25;372(9648):1463-72. doi: 10.1016/S0140-6736(08)61619-0. Lancet. 2008. PMID: 18970976 Clinical Trial.

2

[Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].

Gold R, Hartung HP, Toyka KV. Gold R, et al. Fortschr Neurol Psychiatr. 1995 Jan;63(1):17-29. doi: 10.1055/s-2007-996599. Fortschr Neurol Psychiatr. 1995. PMID: 7883268 Review. German.

3

The blood-brain barrier as target of multiple sclerosis research and therapy. Report of an international scientific meeting, Würzburg, January 23/24, 2004.

Gold R, Ransohoff RM, Sandrock A, Rieckmann P. Gold R, et al. J Neuroimmunol. 2004 Jul;152(1-2):1-4. doi: 10.1016/j.jneuroim.2004.03.014. J Neuroimmunol. 2004. PMID: 15303274 No abstract available.

4

MBP-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.

Linker RA, Gold R. Linker RA, et al. Among authors: gold r. J Immunol. 2004 Sep 1;173(5):2896. doi: 10.4049/jimmunol.173.5.2896. J Immunol. 2004. PMID: 15322142 No abstract available.

5

Towards individualised multiple-sclerosis therapy.

Gold R, Hartung HP. Gold R, et al. Lancet Neurol. 2005 Nov;4(11):693-4. doi: 10.1016/S1474-4422(05)70205-2. Lancet Neurol. 2005. PMID: 16239174 No abstract available.

6

Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases.

Schneider-Gold C, Hartung HP, Gold R. Schneider-Gold C, et al. Among authors: gold r. Muscle Nerve. 2006 Sep;34(3):284-91. doi: 10.1002/mus.20543. Muscle Nerve. 2006. PMID: 16583368 Review.

7

Increased MS relapse rate during assisted reproduction technique.

Hellwig K, Beste C, Brune N, Haghikia A, Müller T, Schimrigk S, Gold R. Hellwig K, et al. Among authors: gold r. J Neurol. 2008 Apr;255(4):592-3. doi: 10.1007/s00415-008-0607-2. Epub 2008 Apr 16. J Neurol. 2008. PMID: 18408881 No abstract available.

8

Use of intravenous immunoglobulin and plasma exchange in neurological disease.

Linker RA, Gold R. Linker RA, et al. Among authors: gold r. Curr Opin Neurol. 2008 Jun;21(3):358-65. doi: 10.1097/WCO.0b013e3282ff5b8f. Curr Opin Neurol. 2008. PMID: 18451723 Review.

9

Allergic and nonallergic delayed infusion reactions during natalizumab therapy.

Hellwig K, Schimrigk S, Fischer M, Haghikia A, Müller T, Chan A, Gold R. Hellwig K, et al. Among authors: gold r. Arch Neurol. 2008 May;65(5):656-8. doi: 10.1001/archneur.65.5.656. Arch Neurol. 2008. PMID: 18474743

10

Spotlight on fumarates.

Lee DH, Linker RA, Gold R. Lee DH, et al. Among authors: gold r. Int MS J. 2008 Mar;15(1):12-8. Int MS J. 2008. PMID: 18713564 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,012 results

Search Page